Mederma to Reduce Appearance of Post Surgical Scars
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01504061|
Recruitment Status : Completed
First Posted : January 5, 2012
Last Update Posted : October 24, 2013
|Condition or disease||Intervention/treatment|
|Scars||Other: Mederma N&I Other: Mederma Ultra Gel|
This is a 10-week research study designed to compare the effect of two gels on the appearance of post surgical scarring of the chest and/or back. The subject will be asked to identify two symmetrical skin growths that they would like to have removed: one on the left chest and/or back and one on the right chest and/or back. Additionally, the subject will identify a third skin growth that they would like removed which is a reasonable distance from the two symmetrical skin growths and will be located either on the back or the chest.
- Healthy male and non pregnant female subjects ≥18 years of age
- have seborrheic keratoses on the right and left chest and/or back
-Subjects with known allergies or sensitivities to ingredients contained in the test product including onion extract and Lidocaine.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||The Comparison of Mederma® N&I to Mederma® Ultra Gel to Reduce the Appearance of Post Surgical Scars|
|Study Start Date :||January 2012|
|Primary Completion Date :||June 2012|
|Study Completion Date :||August 2012|
|Experimental: Mederma Ultra Gel||
Other: Mederma Ultra Gel
Topical gel applied once daily for eight weeks.
|Active Comparator: Mederma N&I||
Other: Mederma N&I
Topical gel applied three times a day for eight weeks.
- Investigator assessment of post-surgical scar appearance (indices are erythema, softness, texture, and overall appearance). This assessment is accompanied by photography and dermaspectrophotometry. [ Time Frame: 10 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01504061
|United States, North Carolina|
|Dermatology, Laser, and Vein Specialists of the Carolinas, PLLC|
|Charlotte, North Carolina, United States, 28207|
|Principal Investigator:||Girish Munavalli, MD, MHS||Dermatology, Laser, and Vein Specialists of Carolinas, PLLC|